177 related articles for article (PubMed ID: 21936877)
21. Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.
Rodriguez-Perez AI; Dominguez-Meijide A; Lanciego JL; Guerra MJ; Labandeira-Garcia JL
Age (Dordr); 2013 Oct; 35(5):1675-90. PubMed ID: 22986582
[TBL] [Abstract][Full Text] [Related]
22. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
[TBL] [Abstract][Full Text] [Related]
23. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
[TBL] [Abstract][Full Text] [Related]
24. L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
Camp DM; Loeffler DA; LeWitt PA
J Neurochem; 2000 Mar; 74(3):1229-40. PubMed ID: 10693956
[TBL] [Abstract][Full Text] [Related]
25. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
Opacka-Juffry J; Ashworth S; Hume SP; Martin D; Brooks DJ; Blunt SB
Neuroreport; 1995 Dec; 7(1):348-52. PubMed ID: 8742486
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys.
Yoshioka I; Tsujihata M; Akanae W; Nonomura N; Okuyama A
Urology; 2011 Apr; 77(4):1007.e9-1007.e14. PubMed ID: 21256551
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.
Rey P; Lopez-Real A; Sanchez-Iglesias S; Muñoz A; Soto-Otero R; Labandeira-Garcia JL
Neurobiol Aging; 2007 Apr; 28(4):555-67. PubMed ID: 16621167
[TBL] [Abstract][Full Text] [Related]
28. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
[TBL] [Abstract][Full Text] [Related]
29. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
Fletcher EJR; Moon LDF; Duty S
BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
[TBL] [Abstract][Full Text] [Related]
30. Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model.
Tripanichkul W; Jaroensuppaperch EO
Int J Neurosci; 2012 May; 122(5):263-70. PubMed ID: 22176529
[TBL] [Abstract][Full Text] [Related]
31. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
Decressac M; Pain S; Chabeauti PY; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A
Neurobiol Aging; 2012 Sep; 33(9):2125-37. PubMed ID: 21816512
[TBL] [Abstract][Full Text] [Related]
33. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.
Boshoff EL; Fletcher EJR; Duty S
Neuropharmacology; 2018 Jul; 137():156-163. PubMed ID: 29698669
[TBL] [Abstract][Full Text] [Related]
35. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
Iczkiewicz J; Rose S; Jenner P
Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
[TBL] [Abstract][Full Text] [Related]
37. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
[TBL] [Abstract][Full Text] [Related]
38. Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.
Kumar A; Singh BK; Ahmad I; Shukla S; Patel DK; Srivastava G; Kumar V; Pandey HP; Singh C
Brain Res; 2012 Feb; 1438():48-64. PubMed ID: 22244881
[TBL] [Abstract][Full Text] [Related]
39. Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice.
Varcin M; Bentea E; Mertens B; Haute CV; Baekelandt V; Michotte Y; Sarre S
J Neurosci Methods; 2011 Nov; 202(2):128-36. PubMed ID: 21782850
[TBL] [Abstract][Full Text] [Related]
40. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.
Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK
Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]